Addiction Treatment Centers

ReDiscover

KCATC

2600 East 12th Street, Kansas City, MO 64127

ReDiscover KCATC is an outpatient facility in Kansas City, MO offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting Medicaid and Medicare.

Licenses and accreditations

  • Commission on Accreditation of Rehabilitation Facilities (CARF)Accredited by CARF, an independent nonprofit accreditor of health and human services.

Kinds of care

Substance use treatment
Treatment for alcohol and drug use.

Settings

Outpatient
Regular appointments while living at home.
Outpatient methadone/buprenorphine or naltrexone treatment
Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.

Medications for opioid use

Buprenorphine used in Treatment
Buprenorphine is used here.
Naltrexone used in Treatment
Naltrexone is used here.
Buprenorphine maintenance
Buprenorphine continued over time to prevent relapse.
Lofexidine or Clonidine detoxification
Lofexidine or clonidine to ease withdrawal during detox.
Prescribes buprenorphine
Prescribes buprenorphine.
Relapse prevention with naltrexone
Naltrexone to help prevent relapse.

Payment

Accepted
Medicaid; Medicare; Federal block grants for substance use and mental health services.
Help with cost
Payment assistance for people who cannot pay the full cost. Ask the facility for details.

Who they serve

Ages served
Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
Sex
Female; Male.
Programs for
Adolescents; Adult men; Adult women; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced sexual abuse; Clients who have experienced trauma; Clients with HIV or AIDS; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Criminal justice (other than DUI/DWI)/Forensic clients; Members of military families; Seniors or older adults; Veterans; Young adults.
Languages
Sign language services for the deaf and hard of hearing.
More details this facility reports
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder.
External Source of Medications Used for Alcohol Use Disorder Treatment
Other contracted prescribing entity.
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Clonidine; Medication for mental disorders; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement.
Treatment Approaches
Brief intervention; Motivational interviewing.
Facility Operation (e.g., Private, Public)
Private non-profit organization.
Assessment/Pre-treatment
Interim services for clients; Outreach to persons in the community; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
Recovery Support Services
Assistance with obtaining social services; Housing services; Mentoring/peer support.
Education and Counseling Services
Substance use disorder education.
Facility Smoking Policy
Smoking not permitted.
Facility Vaping Policy
Vaping not permitted.
Ancillary Services
Case management service; Mental health services; Social skills development; Suicide prevention services; Transportation assistance.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.